EMBO J. 2024 Jan 02.
Alexander T Bahcheli,
Hyun-Kee Min,
Masroor Bayati,
Hongyu Zhao,
Alexander Fortuna,
Weifan Dong,
Irakli Dzneladze,
Jade Chan,
Xin Chen,
Kissy Guevara-Hoyer,
Peter B Dirks,
Xi Huang,
Jüri Reimand.
Ion channels, transporters, and other ion-flux controlling proteins, collectively comprising the "ion permeome", are common drug targets, however, their roles in cancer remain understudied. Our integrative pan-cancer transcriptome analysis shows that genes encoding the ion permeome are significantly more often highly expressed in specific subsets of cancer samples, compared to pan-transcriptome expectations. To enable target selection, we identified 410 survival-associated IP genes in 33 cancer types using a machine-learning approach. Notably, GJB2 and SCN9A show prominent expression in neoplastic cells and are associated with poor prognosis in glioblastoma, the most common and aggressive brain cancer. GJB2 or SCN9A knockdown in patient-derived glioblastoma cells induces transcriptome-wide changes involving neuron projection and proliferation pathways, impairs cell viability and tumor sphere formation in vitro, perturbs tunneling nanotube dynamics, and extends the survival of glioblastoma-bearing mice. Thus, aberrant activation of genes encoding ion transport proteins appears as a pan-cancer feature defining tumor heterogeneity, which can be exploited for mechanistic insights and therapy development.
Keywords: Cancer; Glioblastoma; Ion Channels; Neuron Projection; Target Discovery